Status:
RECRUITING
Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery Stage
Lead Sponsor:
Fundacion Clinic per a la Recerca Biomédica
Collaborating Sponsors:
Hospital Sant Joan de Deu
Conditions:
Anti-NMDA Receptor Encephalitis
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
The encephalitis mediated by antibodies against the NMDA receptor (NMDARe) predominantly affects young adults and children resulting in severe neurologic and psychiatric deficits. After overcoming the...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients ≥12 years old with NMDARe in the post-acute stage of the disease;
- ≤6 months from hospital discharge (acute phase)
- Exclusion Criteria (one of the following):
- Inability to obtain informed consent;
- inability to travel to the center.
Exclusion
Key Trial Info
Start Date :
January 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06183788
Start Date
January 16 2023
End Date
November 30 2025
Last Update
May 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínic de Barcelona
Barcelona, Catalonia, Spain, 08036